<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Lab Med Online</journal-id>
<journal-title-group>
<journal-title>Laboratory Medicine Online</journal-title>
<abbrev-journal-title abbrev-type="publisher">Lab Med Online</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2093-6338</issn>
<publisher>
<publisher-name>Korean Society for Laboratory Medicine</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.47429/lmo.2024.14.4.364</article-id>
<article-id pub-id-type="publisher-id">lmo-14-4-364</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>원저</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Genomic Characterization of <italic>STX16</italic> Deletion in Pseudohypoparathyroidism</article-title>
<trans-title-group>
<trans-title xml:lang="ko">가성부갑상샘저하증에서 <italic>STX16</italic> 유전자 결실의 유전적 특성 규명</trans-title>
</trans-title-group>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name-alternatives>
<name name-style="western" xml:lang="en"><surname>Kim</surname><given-names>Man Jin</given-names></name>
<name name-style="eastern" xml:lang="ko"><surname>김</surname><given-names>만진</given-names></name>
</name-alternatives>
<degrees>M.D.</degrees>
<xref rid="aff1" ref-type="aff">1</xref>
</contrib>
<contrib contrib-type="author">
<name-alternatives>
<name name-style="western" xml:lang="en"><surname>Lee</surname><given-names>Jee-Soo</given-names></name>
<name name-style="eastern" xml:lang="ko"><surname>이</surname><given-names>지수</given-names></name>
</name-alternatives>
<degrees>M.D.</degrees>
<xref rid="aff2" ref-type="aff">2</xref>
</contrib>
<contrib contrib-type="author">
<name-alternatives>
<name name-style="western" xml:lang="en"><surname>Cho</surname><given-names>Sung Im</given-names></name>
<name name-style="eastern" xml:lang="ko"><surname>조</surname><given-names>성임</given-names></name>
</name-alternatives>
<degrees>M.S.</degrees>
<xref rid="aff2" ref-type="aff">2</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2954-3677</contrib-id>
<name-alternatives>
<name name-style="western" xml:lang="en"><surname>Seong</surname><given-names>Moon-Woo</given-names></name>
<name name-style="eastern" xml:lang="ko"><surname>성</surname><given-names>문우</given-names></name>
</name-alternatives><degrees>M.D.</degrees>
<xref rid="cor1" ref-type="corresp"/>
<xref rid="aff2" ref-type="aff">2</xref>
<xref rid="aff3" ref-type="aff">3</xref>
</contrib>
</contrib-group>
<aff xml:lang="en" id="aff1"><label>1</label>Department of Genomic Medicine, Seoul National University Hospital, Seoul, <country>Korea</country></aff>
<aff xml:lang="ko"><label>1</label><institution>서울대학교병원 임상유전체의학</institution></aff>
<aff xml:lang="en" id="aff2"><label>2</label>Department of Laboratory Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, <country>Korea</country></aff>
<aff xml:lang="ko"><label>2</label><institution>서울대학교병원 진단검사의학과</institution></aff>
<aff xml:lang="en" id="aff3"><label>3</label>Cancer Research Institute, Seoul National University, Seoul, <country>Korea</country></aff>
<aff xml:lang="ko"><label>3</label><institution>서울대학교 암연구소</institution></aff>
<author-notes>
<corresp id="cor1"><bold>Corresponding author:</bold> Moon-Woo Seong, M.D., Ph.D., <ext-link ext-link-type="uri" xlink:href="https://orcid.org/0000-0003-2954-3677">https://orcid.org/0000-0003-2954-3677</ext-link>, Department of Laboratory Medicine, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul 03080, Korea, Tel: +82-2-2072-4180, Fax: +82-2-747-0359, E-mail: <email xlink:href="MWSeong@snu.ac.kr">MWSeong@snu.ac.kr</email>; <email xlink:href="MWSeong@gmail.com">MWSeong@gmail.com</email></corresp>
</author-notes>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<pub-date pub-type="epub">
<day>1</day>
<month>10</month>
<year>2024</year>
</pub-date>
<volume>14</volume>
<issue>4</issue>
<fpage>364</fpage>
<lpage>368</lpage>
<history>
<date date-type="received">
<day>21</day>
<month>5</month>
<year>2024</year>
</date>
<date date-type="rev-recd">
<day>19</day>
<month>8</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>19</day>
<month>8</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>&#169; 2024, Laboratory Medicine Online</copyright-statement>
<copyright-year>2024</copyright-year>
<license license-type="open-access">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0">http://creativecommons.org/licenses/by-nc/4.0</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<abstract>
<sec sec-type="background">
<title>Background</title>
<p>Pseudohypoparathyroidism type Ib (PHP-1b) is a rare imprinting disorder characterized by renal parathyroid hormone resistance, but without the physical features of Albright hereditary osteodystrophy. A common heterozygous 3-kb deletion of <italic>STX16</italic> was previously reported in multiple unrelated probands. This deletion causes isolated loss of methylation at <italic>GNAS</italic> exons A/B. We aimed to identify <italic>STX16</italic> deletions and the exact breakpoints to gain insights into the mechanism of <italic>STX16</italic> deletion.</p>
</sec>
<sec sec-type="methods">
<title>Methods</title>
<p>We investigated 10 patients who were diagnosed with pseudohypoparathyroidism type Ib, but did not have any pathogenic variants in <italic>GNAS</italic>. A methylation-specific multiplex ligation-dependent probe amplification assay of <italic>STX16</italic> was performed to assess allelic dosage. Junction PCR and Sanger sequencing were performed around the presumptive breakpoint area to determine the exact breakpoint.</p>
</sec>
<sec sec-type="results">
<title>Results</title>
<p><italic>STX16</italic> gene deletion was detected in two of the 10 probands (20%). The deletion range was the same for both probands, ranging from g.57,243,566 to g.57,246,545 (2,979 bp), according to the February 2009 human reference sequence (hg19, build37), which is consistent with previous reports. The 5&#8217; and 3&#8217; break points were located in the mammalian-wide interspersed repeats (MIRs) sequences suggesting MIR-mediated non-allelic homologous recombination as the putative mechanism for the common <italic>STX16</italic> 3-kb deletion.</p>
</sec>
<sec sec-type="conclusions">
<title>Conclusions</title>
<p>Non-allelic homologous recombination is a putative mechanism of <italic>STX16</italic> deletion in our patients. To the best of our knowledge, this is the first study to show that MIRs are involved in genomic rearrangements.</p>
</sec>
</abstract>
<trans-abstract xml:lang="ko">
<sec sec-type="배경">
<title>배경</title>
<p>가성부갑상선기능저하증 1b형(PHP-1b)은 드문 각인 장애로, 신장에서 부갑상선 호르몬 저항성을 특징으로 하지만, Albright 유전성 골이영양증의 신체적 특징은 나타나지 않는다. 이전에 보고된 바에 따르면, 여러 비관련 환자들에서 공통적으로 나타나는 이형접합성 3kb <italic>STX16</italic> 결실이 있다. 이 결실은 <italic>GNAS</italic> 유전자 A/B 엑손에서 메틸화 문제를 유발한다. 저자들은 <italic>STX16</italic> 결실과 정확한 절단점을 확인하여 <italic>STX16</italic> 결실의 메커니즘을 규명하고자 하였다.</p>
</sec>
<sec sec-type="방법">
<title>방법</title>
<p>저자들은 PHP-1b로 진단받았으나 <italic>GNAS</italic> 유전자에 병원성 서열 변이가 없는 10명의 환자를 대상으로 연구하였다. <italic>STX16</italic>의 복제수를 평가하기 위해 메틸화 특이적 복합결찰 의존 탐침 증폭법(methylation-specific multiplex ligation-dependent probe amplification, MS-MLPA) 분석을 수행하였다. 절단점 부근에서의 PCR과 생거 시퀀싱을 통해 정확한 절단점을 결정했다.</p>
</sec>
<sec sec-type="결과">
<title>결과</title>
<p>10명의 환자 중 2명(20%)에서 <italic>STX16</italic> 유전자 결실이 확인되었다. 두 환자의 결실 범위는 g.57,243,566에서 g.57,246,545까지로 동일했으며, 이는 이전 보고와 일치하는 2,979 bp에 해당한다(2009년 2월 인간 참조 서열 hg19, build37 기준).</p>
</sec>
<sec sec-type="결론">
<title>결론</title>
<p>5&#8242; 및 3&#8242; 절단점은 mammalian-wide interspersed repeats (MIRs) 내에 위치해 있으며, 이는 <italic>STX16</italic>의 일반적인 3-kb 결실에 대한 가설적 메커니즘으로서 MIRs 매개 비대립동종재조합(nonallelic homologous recombination, NAHR)을 시사한다. 저자들이 아는 한, 이 연구는 MIR가 유전체 재배열에 관여한다는 것을 처음으로 보여준 연구이다.</p>
</sec>
</trans-abstract>
<kwd-group>
<kwd>Pseudohypoparathyroidism</kwd>
<kwd>Gene rearrangement</kwd>
<kwd>DNA copy number variations</kwd>
<kwd><italic>STX16</italic></kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>INTRODUCTION</title>
<p>Disorders of <italic>GNAS</italic> inactivation include pseudohypoparathyroidism types Ia, Ib, and Ic (PHP-Ia, -Ib, and -Ic), pseudopseudohypoparathyroidism (PPHP), progressive osseous heteroplasia (POH), and osteoma cutis (OC). PHP-Ia and PHP-Ic feature hormone resistance and characteristics of Albright hereditary osteodystrophy (AHO), such as short stature and subcutaneous ossification. PHP-Ib is primarily involved in parathyroid hormone resistance. PPHP manifests as AHO without hormone resistance. POH involves progressive bone formation in the muscles and fascia, whereas OC involves ossification of the dermis and subcutaneous tissues. Diagnosis involves identifying the clinical features and genetic or epigenetic alterations affecting the <italic>GNAS</italic> locus. <italic>GNAS</italic> inactivation can be caused by pathogenic variants, imprinting issues, epimutations, or paternal 20q disomy. PPHP and POH/OC are caused by pathogenic variants of the paternal <italic>GNAS</italic> allele [<xref rid="ref1" ref-type="bibr">1</xref>].</p>
<p>PHP-1b is a rare imprinting disorder characterized by renal parathyroid hormone (PTH) resistance, but the absence of physical features of AHO [<xref rid="ref2" ref-type="bibr">2</xref>]. This distinguishes PHP-Ib from PHP-Ia, which results from mutations in the <italic>GNAS</italic> gene encoding the G protein &#945; subunit. The autosomal-dominant form of PHP-Ib (ADPHP-Ib) is linked to chromosome 20q13.3, where the <italic>GNAS</italic> locus is located. Notably, loss of methylation of exon the A/B differentially methylated region (DMR) of <italic>GNAS</italic> has been observed in both sporadic PHP-Ib cases and affected members of AD-PHP-Ib families. Recent findings indicate that affected individuals from 12 unrelated AD-PHP-Ib families and four patients with sporadic PHP-Ib, but not healthy controls, are heterozygous for an approximately 3 kb microdeletion approximately 220 kb upstream of <italic>GNAS</italic> exon A/B. This deleted region includes three exons of the <italic>STX16</italic> gene, which does not show any imprinting. Microdeletion leads to loss of methylation at exons A/B, without affecting other <italic>GNAS</italic> DMRs, suggesting that it disrupts the cis-acting element necessary for exon A/B methylation, causing renal PTH resistance in AD-PHP-Ib [<xref rid="ref3" ref-type="bibr">3</xref>].</p>
<p>However, there has been no research on the causes of recurrent 3-kb microdeletion. Therefore, we aimed to elucidate the putative mechanism through genomic characterization of the 3-kb microdeletion.</p>
</sec>
<sec sec-type="materials|methods">
<title>MATERIALS AND METHODS</title>
<sec>
<title>1. Informed consent and study enrollment</title>
<p>Ten unrelated patients with PHP who visited Seoul National University Hospital between March 2009 and January 2019 were enrolled in the Korean Genetic Diagnosis Program for Rare Diseases Phase II [<xref rid="ref4" ref-type="bibr">4</xref>]. This study was conducted in accordance with the tenets of the Declaration of Helsinki, and the protocol was approved by the Institutional Review Board of the Seoul National University Hospital. Informed consent was obtained from all enrolled participants.</p>
</sec>
<sec>
<title>2. Methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA)</title>
<p>To investigate the genetic and epigenetic changes in the samples, the MS-MLPA technique was employed using the SALSA MSMLPA probemix ME031-B2 <italic>GNAS</italic> kit, following the manufacturer&#8217; s instructions (MRC-Holland, Amsterdam, Netherlands). Genomic DNA (200 ng) was denatured at 98&#176;C for 5 minutes and hybridized with the ME031-B2 probe mix for 16 hours at 60&#176;C. After hybridization, the product was divided into two tubes for copy number and methylation analyses using a methylation-sensitive endonuclease. The PCR products were analyzed on an ABI 3130xl capillary sequencer (Applied Biosystems, Waltham, MA, USA), and the data were processed using GeneMarker v.1.51 software (SoftGenetics, State College, PA, USA). Peak intensities were normalized to internal control probes, and the intensity ratios of identical probes from the samples were compared with those of the controls.</p>
</sec>
<sec>
<title>3. Junction PCR and Sanger sequencing around the breakpoint areas</title>
<p>PCR primers were designed based on the consensus sequences from the split-read junctions. The amplified products were sequenced using an ABI PRISM 3730 xl DNA Analyzer (Applied Biosystems) with the BigDye Terminator v.3.1 Cycle Sequencing Kit (Applied Biosystems). Sequence analysis was conducted using Sequencher software (Gene Codes Corporation, Ann Arbor, MI, USA).</p>
</sec>
<sec>
<title>4. Mapping of repetitive elements around the breakpoint areas</title>
<p>Repetitive elements within the breakpoint regions were identified using RepeatMasker in the UCSC Genome Browser (<ext-link ext-link-type="uri" xlink:href="https://genome.ucsc.edu/">https://genome.ucsc.edu/</ext-link>). Sequence similarities were assessed using ClustalW (<ext-link ext-link-type="uri" xlink:href="https://www.genome.jp/tools-bin/clustalw">https://www.genome.jp/tools-bin/clustalw</ext-link>).</p>
</sec>
</sec>
<sec sec-type="results">
<title>RESULTS</title>
<sec>
<title>1. Mutation analysis</title>
<p><xref rid="T1" ref-type="table">Table 1</xref> summarizes the 10 cases, their classifications, and the genetic testing results. <xref rid="T1" ref-type="table">Table 1</xref> comprises data for individuals classified as having PHP-1a and PHP-1b. Genetic testing revealed various abnormalities, such as paternal 20q disomy, <italic>STX16</italic> 2,979bp deletion, and mutations in the <italic>GNAS</italic> gene. Some patients exhibited no detectable genetic abnormalities.</p>
<p>A 2,979 bp deletion of <italic>STX16</italic> was detected in two of the 10 probands (20%). Heterozygous deletions in exons 5 and 6 of the <italic>STX16</italic> gene were initially identified using MLPA. The deletion of exon 7, which was not detected using MLPA, was suspected based on the results of an in-house copy number variation screening method [<xref rid="ref5" ref-type="bibr">5</xref>]. Subsequently, junction PCR was performed. Finally, we confirmed a 2,979 bp deletion (chr20:57,243,566&#8211;57,246,545) encompassing exons 5&#8211;7 (<xref rid="F1" ref-type="fig">Fig. 1</xref>).</p>
</sec>
<sec>
<title>2. Junction sequence analyses</title>
<p>When analyzing similarity using ClustalW within 1-kb upstream and downstream of the breakpoints, a 319 bp homologous region was detected, which showed only 2 bp mismatches, as depicted in <xref rid="F2" ref-type="fig">Fig. 2</xref> (bottom). This region contains one of the mammalian-wide interspersed repeats (MIRs), MIRb, which spans 191 bp. A 1-bp difference was observed between the upstream and downstream MIRb sequences. The upstream homologous sequence was located within intron 4 of <italic>STX16</italic>, whereas the downstream homologous sequence was located within intron 7.</p>
</sec>
</sec>
<sec sec-type="discussion">
<title>DISCUSSION</title>
<p><italic>STX16</italic> gene deletion was detected in two of the 10 probands (20%). This deletion range is consistent with previous reports [<xref rid="ref6" ref-type="bibr">6</xref><xref rid="ref7" ref-type="bibr"/><xref rid="ref8" ref-type="bibr"/><xref rid="ref9" ref-type="bibr"/>-<xref rid="ref10" ref-type="bibr">10</xref>]. Most genomic rearrangements occur through mechanisms such as non-allelic homologous recombination (NAHR), nonhomologous end joining, fork stalling, and template switching [<xref rid="ref11" ref-type="bibr">11</xref>]. However, the presence of homologous sequences in proximity to breakpoints favors rearrangements mediated by NAHR [<xref rid="ref12" ref-type="bibr">12</xref>]. While NAHR mediated by Alu elements is well documented [<xref rid="ref13" ref-type="bibr">13</xref>, <xref rid="ref14" ref-type="bibr">14</xref>], to the best of our knowledge, this is the first cases that NAHR via MIRs is a putative mechanism of rearrangement.</p>
<p>Short interspersed elements are widespread in mammalian genomes. The significant diversity of these repeats across placental orders suggests independent amplification of each lineage following mammalian radiation. Here, we introduce an ancient family of repeats, termed MIRs, whose sequence variation and widespread presence among placental mammals, marsupials, and monotremes indicate amplification during the Mesozoic era. With approximately 120,000 copies still identifiable in the human genome (0.2&#8211;0.3% of DNA), MIRs serve as a &#8220;fossilized&#8221; record of a substantial genetic event preceding the radiation of placental orders [<xref rid="ref15" ref-type="bibr">15</xref>].</p>
<p>However, the evolutionary role of repeated element sequences in genomes remains debatable. A recent study suggested that an expanded repertoire of repeat elements may enhance organismal fitness by promoting somatic diversity, akin to the beneficial genetic diversity observed in microbial populations. Specifically, the characterization of somatic recombination involving Alu and L1 in this study provides a foundation for future investigations into the dynamics of somatic NAHR events and their implications for genome structure and function [<xref rid="ref16" ref-type="bibr">16</xref>]. We believe that our study will contribute to broadening our understanding of the mechanisms underlying genomic rearrangements.</p>
<p>In conclusion, the findings of this study suggest that the common 2,979 deletion of <italic>STX16</italic> is mediated by MIR-mediated nonallelic homologous recombination.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="coi-statement">
<p><bold>Conflicts of Interest</bold></p>
<p>None declared.</p>
</fn>
</fn-group>
<ref-list>
<title>REFERENCES</title>
<ref id="ref1">
<label>1</label>
<element-citation publication-type="web">
<person-group person-group-type="author">
<name><surname>Haldeman-Englert</surname><given-names>CR</given-names></name>
<name><surname>Hurst</surname><given-names>ACE</given-names></name>
<name><surname>Levine</surname><given-names>MA</given-names></name>
</person-group>
<person-group person-group-type="editor">
<name><surname>Adam</surname><given-names>MP</given-names></name>
<name><surname>Feldman</surname><given-names>J</given-names></name>
<name><surname>Mirzaa</surname><given-names>GM</given-names></name>
<etal/>
</person-group>
<year>1993-2024</year>
<part-title>Disorders of GNAS Inactivation. 2017 Oct 26</part-title>
<source>GeneReviews&#174; [Internet]</source>
<publisher-name>University of Washington, Seattle</publisher-name>
<publisher-loc>Seattle (WA)</publisher-loc>
<comment>Available from: <uri>https://www.ncbi.nlm.nih.gov/books/NBK459117/</uri></comment>
</element-citation>
</ref>
<ref id="ref2">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Mantovani</surname><given-names>G</given-names></name>
<name><surname>Bastepe</surname><given-names>M</given-names></name>
<name><surname>Monk</surname><given-names>D</given-names></name>
<name><surname>de Sanctis</surname><given-names>L</given-names></name>
<name><surname>Thiele</surname><given-names>S</given-names></name>
<name><surname>Usardi</surname><given-names>A</given-names></name>
<etal/>
</person-group>
<year>2018</year>
<article-title>Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement</article-title>
<source>Nat Rev Endocrinol</source>
<volume>14</volume>
<fpage>476</fpage>
<lpage>500</lpage>
<pub-id pub-id-type="doi">10.1038/s41574-018-0042-0</pub-id>
<pub-id pub-id-type="pmid">29959430</pub-id>
<pub-id pub-id-type="pmcid">PMC6541219</pub-id>
</element-citation>
</ref>
<ref id="ref3">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Bastepe</surname><given-names>M</given-names></name>
<name><surname>Fr&#246;hlich</surname><given-names>LF</given-names></name>
<name><surname>Hendy</surname><given-names>GN</given-names></name>
<name><surname>Indridason</surname><given-names>OS</given-names></name>
<name><surname>Josse</surname><given-names>RG</given-names></name>
<name><surname>Koshiyama</surname><given-names>H</given-names></name>
<etal/>
</person-group>
<year>2003</year>
<article-title>Autosomal dominant pseudohypoparathyroidism type Ib is associated with a heterozygous microdeletion that likely disrupts a putative imprinting control element of GNAS</article-title>
<source>J Clin Invest</source>
<volume>112</volume>
<fpage>1255</fpage>
<lpage>63</lpage>
<pub-id pub-id-type="doi">10.1172/JCI19159</pub-id>
</element-citation>
</ref>
<ref id="ref4">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kim</surname><given-names>MJ</given-names></name>
<name><surname>Kim</surname><given-names>B</given-names></name>
<name><surname>Lee</surname><given-names>H</given-names></name>
<name><surname>Lee</surname><given-names>JS</given-names></name>
<name><surname>Chae</surname><given-names>SW</given-names></name>
<name><surname>Shin</surname><given-names>HS</given-names></name>
<etal/>
</person-group>
<year>2023</year>
<article-title>The Korean Genetic Diagnosis Program for Rare Disease Phase II: outcomes of a 6-year national project</article-title>
<source>Eur J Hum Genet</source>
<volume>31</volume>
<fpage>1147</fpage>
<lpage>53</lpage>
<pub-id pub-id-type="doi">10.1038/s41431-023-01415-8</pub-id>
<pub-id pub-id-type="pmid">37414863</pub-id>
<pub-id pub-id-type="pmcid">PMC10545669</pub-id>
</element-citation>
</ref>
<ref id="ref5">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kim</surname><given-names>MJ</given-names></name>
<name><surname>Lee</surname><given-names>S</given-names></name>
<name><surname>Yun</surname><given-names>H</given-names></name>
<name><surname>Cho</surname><given-names>SI</given-names></name>
<name><surname>Kim</surname><given-names>B</given-names></name>
<name><surname>Lee</surname><given-names>JS</given-names></name>
<etal/>
</person-group>
<year>2022</year>
<article-title>Consistent count region-copy number variation (CCR-CNV): an expandable and robust tool for clinical diagnosis of copy number variation at the exon level using next-generation sequencing data</article-title>
<source>Genet Med</source>
<volume>24</volume>
<fpage>663</fpage>
<lpage>72</lpage>
<pub-id pub-id-type="doi">10.1016/j.gim.2021.10.025</pub-id>
<pub-id pub-id-type="pmid">34906491</pub-id>
</element-citation>
</ref>
<ref id="ref6">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Chu</surname><given-names>X</given-names></name>
<name><surname>Zhu</surname><given-names>Y</given-names></name>
<name><surname>Wang</surname><given-names>O</given-names></name>
<name><surname>Nie</surname><given-names>M</given-names></name>
<name><surname>Quan</surname><given-names>T</given-names></name>
<name><surname>Xue</surname><given-names>Y</given-names></name>
<etal/>
</person-group>
<year>2018</year>
<article-title>Clinical and genetic characteristics of pseudohypoparathyroidism in the Chinese population</article-title>
<source>Clin Endocrinol (Oxf)</source>
<volume>88</volume>
<fpage>285</fpage>
<lpage>94</lpage>
<pub-id pub-id-type="doi">10.1111/cen.13516</pub-id>
</element-citation>
</ref>
<ref id="ref7">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Danzig</surname><given-names>J</given-names></name>
<name><surname>Li</surname><given-names>D</given-names></name>
<name><surname>Jan de Beur</surname><given-names>S</given-names></name>
<name><surname>Levine</surname><given-names>MA</given-names></name>
</person-group>
<year>2021</year>
<article-title>High-throughput molecular analysis of pseudohypoparathyroidism 1b patients teveals novel genetic and epigenetic defects</article-title>
<source>J Clin Endocrinol Metab</source>
<volume>106</volume>
<fpage>e4603</fpage>
<lpage>20</lpage>
<pub-id pub-id-type="doi">10.1210/clinem/dgab460</pub-id>
</element-citation>
</ref>
<ref id="ref8">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Elli</surname><given-names>FM</given-names></name>
<name><surname>de Sanctis</surname><given-names>L</given-names></name>
<name><surname>Peverelli</surname><given-names>E</given-names></name>
<name><surname>Bordogna</surname><given-names>P</given-names></name>
<name><surname>Pivetta</surname><given-names>B</given-names></name>
<name><surname>Miolo</surname><given-names>G</given-names></name>
<etal/>
</person-group>
<year>2014</year>
<article-title>Autosomal dominant pseudohypoparathyroidism type Ib: a novel inherited deletion ablating STX16 causes loss of imprinting at the A/B DMR</article-title>
<source>J Clin Endocrinol Metab</source>
<volume>99</volume>
<fpage>E724</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1210/jc.2013-3704</pub-id>
<pub-id pub-id-type="pmid">24438374</pub-id>
</element-citation>
</ref>
<ref id="ref9">
<label>9</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kiuchi</surname><given-names>Z</given-names></name>
<name><surname>Reyes</surname><given-names>M</given-names></name>
<name><surname>Brickman</surname><given-names>AS</given-names></name>
<name><surname>J&#252;ppner</surname><given-names>H</given-names></name>
</person-group>
<year>2021</year>
<article-title>A distinct variant of pseudohypoparathyroidism (PHP) first characterized some 41 years ago is caused by the 3-kb STX16 deletion</article-title>
<source>JBMR Plus</source>
<volume>5</volume>
<elocation-id>e10505</elocation-id>
<pub-id pub-id-type="doi">10.1002/jbm4.10505</pub-id>
<pub-id pub-id-type="pmid">34258502</pub-id>
<pub-id pub-id-type="pmcid">PMC8260810</pub-id>
<pub-id pub-id-type="doaj">f5e78811d5224d85b7f9dad80d62fd49</pub-id>
</element-citation>
</ref>
<ref id="ref10">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Linglart</surname><given-names>A</given-names></name>
<name><surname>Gensure</surname><given-names>RC</given-names></name>
<name><surname>Olney</surname><given-names>RC</given-names></name>
<name><surname>J&#252;ppner</surname><given-names>H</given-names></name>
<name><surname>Bastepe</surname><given-names>M</given-names></name>
</person-group>
<year>2005</year>
<article-title>A novel STX16 deletion in autosomal dominant pseudohypoparathyroidism type Ib redefines the boundaries of a cis-acting imprinting control element of GNAS</article-title>
<source>Am J Hum Genet</source>
<volume>76</volume>
<fpage>804</fpage>
<lpage>14</lpage>
<pub-id pub-id-type="doi">10.1086/429932</pub-id>
<pub-id pub-id-type="pmid">15800843</pub-id>
<pub-id pub-id-type="pmcid">PMC1199370</pub-id>
</element-citation>
</ref>
<ref id="ref11">
<label>11</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Hastings</surname><given-names>PJ</given-names></name>
<name><surname>Lupski</surname><given-names>JR</given-names></name>
<name><surname>Rosenberg</surname><given-names>SM</given-names></name>
<name><surname>Ira</surname><given-names>G</given-names></name>
</person-group>
<year>2009</year>
<article-title>Mechanisms of change in gene copy number</article-title>
<source>Nat Rev Genet</source>
<volume>10</volume>
<fpage>551</fpage>
<lpage>64</lpage>
<pub-id pub-id-type="doi">10.1038/nrg2593</pub-id>
</element-citation>
</ref>
<ref id="ref12">
<label>12</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kataoka</surname><given-names>M</given-names></name>
<name><surname>Aimi</surname><given-names>Y</given-names></name>
<name><surname>Yanagisawa</surname><given-names>R</given-names></name>
<name><surname>Ono</surname><given-names>M</given-names></name>
<name><surname>Oka</surname><given-names>A</given-names></name>
<name><surname>Fukuda</surname><given-names>K</given-names></name>
<etal/>
</person-group>
<year>2013</year>
<article-title>Alu-mediated nonallelic homologous and nonhomologous recombination in the BMPR2 gene in heritable pulmonary arterial hypertension</article-title>
<source>Genet Med</source>
<volume>15</volume>
<fpage>941</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1038/gim.2013.41</pub-id>
</element-citation>
</ref>
<ref id="ref13">
<label>13</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ferlini</surname><given-names>A</given-names></name>
<name><surname>Gali&#233;</surname><given-names>N</given-names></name>
<name><surname>Merlini</surname><given-names>L</given-names></name>
<name><surname>Sewry</surname><given-names>C</given-names></name>
<name><surname>Branzi</surname><given-names>A</given-names></name>
<name><surname>Muntoni</surname><given-names>F</given-names></name>
</person-group>
<year>1998</year>
<article-title>A novel Alu-like element rearranged in the dystrophin gene causes a splicing mutation in a family with X-linked dilated cardiomyopathy</article-title>
<source>Am J Hum Genet</source>
<volume>63</volume>
<fpage>436</fpage>
<lpage>46</lpage>
<pub-id pub-id-type="doi">10.1086/301952</pub-id>
</element-citation>
</ref>
<ref id="ref14">
<label>14</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Montagna</surname><given-names>M</given-names></name>
<name><surname>Santacatterina</surname><given-names>M</given-names></name>
<name><surname>Torri</surname><given-names>A</given-names></name>
<name><surname>Menin</surname><given-names>C</given-names></name>
<name><surname>Zullato</surname><given-names>D</given-names></name>
<name><surname>Chieco-Bianchi</surname><given-names>L</given-names></name>
<etal/>
</person-group>
<year>1999</year>
<article-title>Identification of a 3 kb Alu-mediated <italic>BRCA1</italic> gene rearrangement in two breast/ovarian cancer families</article-title>
<source>Oncogene</source>
<volume>18</volume>
<fpage>4160</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="doi">10.1038/sj.onc.1202754</pub-id>
</element-citation>
</ref>
<ref id="ref15">
<label>15</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Jurka</surname><given-names>J</given-names></name>
<name><surname>Zietkiewicz</surname><given-names>E</given-names></name>
<name><surname>Labuda</surname><given-names>D</given-names></name>
</person-group>
<year>1995</year>
<article-title>Ubiquitous mammalian-wide interspersed repeats (MIRs) are molecular fossils from the mesozoic era</article-title>
<source>Nucleic Acids Res</source>
<volume>23</volume>
<fpage>170</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="doi">10.1093/nar/23.1.170</pub-id>
<pub-id pub-id-type="pmid">7870583</pub-id>
<pub-id pub-id-type="pmcid">PMC306646</pub-id>
</element-citation>
</ref>
<ref id="ref16">
<label>16</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Pascarella</surname><given-names>G</given-names></name>
<name><surname>Hon</surname><given-names>CC</given-names></name>
<name><surname>Hashimoto</surname><given-names>K</given-names></name>
<name><surname>Busch</surname><given-names>A</given-names></name>
<name><surname>Luginb&#252;hl</surname><given-names>J</given-names></name>
<name><surname>Parr</surname><given-names>C</given-names></name>
<etal/>
</person-group>
<year>2022</year>
<article-title>Recombination of repeat elements generates somatic complexity in human genomes</article-title>
<source>Cell</source>
<volume>185</volume>
<fpage>3025</fpage>
<lpage>40</lpage>
<comment>e6</comment>
<pub-id pub-id-type="doi">10.1016/j.cell.2022.06.032</pub-id>
<pub-id pub-id-type="pmid">35882231</pub-id>
</element-citation>
</ref>
</ref-list>
<sec sec-type="display-objects">
<title>Figures and Table</title>
<fig id="F1" position="float">
<label>Fig. 1</label>
<caption>
<p>Detection of the 2,979 bp deletion of <italic>STX16</italic>. Heterozygous deletion of exons 5 and 6 of the <italic>STX16</italic> gene was initially identified using multiplex ligation-dependent probe amplification (MLPA). The deletion of exon 7, which was not detected using MLPA, was suspected base on the results of an in-house method. Junction PCR was subsequently performed. Finally, we confirmed the 2,979 bp deletion encompassing exon 5 to exon 7.</p>
</caption>
<graphic xlink:href="lmo-14-4-364-f1.tif"/>
</fig>
<fig id="F2" position="float">
<label>Fig. 2</label>
<caption>
<p>Junction analysis of the 2,979 bp deletion of <italic>STX16</italic>. The distribution of repetitive elements around the 2,979 deletion of <italic>STX16</italic> is shown. Two MIRbs are indicated by green squares. Below, the 319 bp homology sequence is displayed. The green text corresponds to MIRb, and the blue text represents the remaining sequences. The upstream homologous sequences and the downstream homologous sequences were completely identical except for 2 bp.</p>
<p>Abbreviation: MIRb, mammalian-wide interspersed repeat b.</p>
</caption>
<graphic xlink:href="lmo-14-4-364-f2.tif"/>
</fig>
<table-wrap id="T1" position="float">
<label>Table 1</label>
<caption>
<p>Results of mutation analysis</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr style="background-color:#e2edbc;">
<th valign="middle" align="left">Case No.</th>
<th valign="middle" align="center">Sex/age</th>
<th valign="middle" align="center">Classification</th>
<th valign="middle" align="center">Result of genetic testing</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="center">1</td>
<td valign="top" align="center">F/31</td>
<td valign="top" align="center">PHP-1a</td>
<td valign="top" align="center">prob. paternal 20q disomy</td>
</tr>
<tr style="background-color:#f3f4f4;">
<td valign="top" align="center">2</td>
<td valign="top" align="center">F/15</td>
<td valign="top" align="center">PHP-1b</td>
<td valign="top" align="center"><italic>STX16</italic> 2,979bp deletion</td>
</tr>
<tr>
<td valign="top" align="center">3</td>
<td valign="top" align="center">M/2</td>
<td valign="top" align="center">PHP-1a</td>
<td valign="top" align="center"><italic>GNAS</italic>, c.794G&#62;A, p.Arg265His, heterozygote</td>
</tr>
<tr style="background-color:#f3f4f4;">
<td valign="top" align="center">4</td>
<td valign="top" align="center">M/8</td>
<td valign="top" align="center">PHP-1a</td>
<td valign="top" align="center"><italic>GNAS</italic>, c.348dup, p.Val117Argfs*23, heterozygote</td>
</tr>
<tr>
<td valign="top" align="center">5</td>
<td valign="top" align="center">F/13</td>
<td valign="top" align="center">PHP-1b</td>
<td valign="top" align="center"><italic>STX16</italic> 2,979bp deletion</td>
</tr>
<tr style="background-color:#f3f4f4;">
<td valign="top" align="center">6</td>
<td valign="top" align="center">M/22</td>
<td valign="top" align="center">PHP-1b</td>
<td valign="top" align="center">negative</td>
</tr>
<tr>
<td valign="top" align="center">7</td>
<td valign="top" align="center">F/34</td>
<td valign="top" align="center">PHP-1b</td>
<td valign="top" align="center">paternal 20q disomy</td>
</tr>
<tr style="background-color:#f3f4f4;">
<td valign="top" align="center">8</td>
<td valign="top" align="center">F/10</td>
<td valign="top" align="center">PHP-1a</td>
<td valign="top" align="center">negative</td>
</tr>
<tr>
<td valign="top" align="center">9</td>
<td valign="top" align="center">M/9</td>
<td valign="top" align="center">PHP-1a</td>
<td valign="top" align="center">negative</td>
</tr>
<tr style="background-color:#f3f4f4;">
<td valign="top" align="center">10</td>
<td valign="top" align="center">M/21</td>
<td valign="top" align="center">PHP-1b</td>
<td valign="top" align="center">paternal 20q disomy</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="t1fn1">
<p>Abbreviations: PHP, pseudohypoparathyroidism; prob, probable.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
</back>
</article>